Equatorial Guinea vs Türkiye: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Equatorial Guinea
2.0%
in 2024
Türkiye
0.0%
in 2024
Equatorial Guinea rank
12th
Türkiye rank
13th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Equatorial Guinea
- Türkiye
How they compare
Equatorial Guinea currently reports 2.0% against 0.0% in Türkiye, a difference of 2.0%.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Equatorial Guinea ranks 12th and Türkiye ranks 13th of 215 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 0.1% | 2.2% | Equatorial Guinea |
| 2020s | 2.1% | 0.1% | 2.0% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Equatorial Guinea or Türkiye?
- Equatorial Guinea, at 2.0% against 0.0% in Türkiye as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Equatorial Guinea and Türkiye?
- 2.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and Türkiye rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Equatorial Guinea ranks 12th and Türkiye ranks 13th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.